+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dystonia Drug"

Dystonia - Pipeline Insight, 2022 - Product Thumbnail Image

Dystonia - Pipeline Insight, 2022

  • Clinical Trials
  • June 2022
  • 60 Pages
  • Global
From
From
Cervical Dystonia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cervical Dystonia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cervical Dystonia - Pipeline Insight, 2020 - Product Thumbnail Image

Cervical Dystonia - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
  • Global
From
Global Cervical Dystonia Therapeutics Market 2021-2025 - Product Thumbnail Image

Global Cervical Dystonia Therapeutics Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
  • Global
From
From
  • 14 Results (Page 1 of 1)
Loading Indicator

The Dystonia Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat dystonia, a neurological disorder characterized by involuntary muscle contractions and spasms. These drugs are used to reduce the severity of symptoms, such as muscle spasms, cramps, and tremors. Commonly prescribed drugs include botulinum toxin, anticholinergics, and dopamine agonists. Other treatments, such as physical therapy, may also be used to manage dystonia. The Dystonia Drug market is highly competitive, with many companies offering products to treat the disorder. Some of the major players in the market include Allergan, Merz Pharmaceuticals, Teva Pharmaceuticals, AbbVie, and Ipsen. Show Less Read more